课题基金 / 基金详情

Controlling Exosome Noncoding RNA Cargo for Enhanced Wound Healing

Controlling Exosome Noncoding RNA Cargo for Enhanced Wound Healing
控制外泌体非编码 RNA 货物以增强伤口愈合
批准号:
10398820
负责人:
Steven Michael Jay
金额:
$38.85万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-04-01 至 2025-03-31

项目摘要

项目成果

Steven Michael Jay的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Exosomes have emerged as potential therapeutic vectors for repair of non-healing wounds, which continue to be a significant source of morbidity and represent a substantial financial burden to patients and health care systems in general. However, the therapeutic potency – and thus the translational potential – of exosomes for wound repair is limited, as exosomes contain low amounts of nucleic acid cargo, such as microRNAs (miRNAs), which are critical to defining exosome bioactivity. Towards overcoming this limitation, we have developed a novel ethanol conditioning approach for endothelial cell-derived exosomes. This method reduces anti- angiogenic miRNA cargo and increases pro-angiogenic long non-coding RNA cargo in these exosomes, leading to an overall increase in angiogenic bioactivity. Angiogenic dysfunction is a hallmark of non-healing wounds, thus these enhanced exosome formulations have therapeutic potential in wound repair. Our team of bioengineers and clinicians will test approaches to further exert control over endothelial exosome non-coding RNA cargo and bioactivity via environmental conditioning approaches (Aim 1) and exogenous loading techniques (Aim 2). We will further test the therapeutic efficacy of enhanced exosomes in excisional, diabetic, and burn injury wound repair models (Aim 3) to identify the most promising avenue for further translational investigations. Overall, these studies will promote the development of a new class of therapeutics for non-healing wounds that could benefit millions of patients.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/acssynbio.0c00179
发表时间: 2020-10-16
期刊: ACS synthetic biology
影响因子: 4.7
作者: [Hauk P, Stephens K, Virgile C, VanArsdale E, Pottash AE, Schardt JS, Jay SM, Sintim HO, Bentley WE]
通讯作者: Bentley WE
DOI: 10.1208/s12248-017-0160-y
发表时间: 2017-11-27
期刊: The AAPS journal
影响因子: --
作者: [Jeyaram A, Jay SM]
通讯作者: Jay SM
Pioneering use of genetic analysis for CDH1 to identify candidates for prophylactic total gastrectomy to prevent hereditary diffuse gastric cancer.
开创性地使用 CDH1 基因分析来确定预防性全胃切除术的候选者,以预防遗传性弥漫性胃癌。
DOI: 10.1136/egastro-2023-100017
发表时间: 2023
期刊: eGastroenterology
影响因子: --
作者: [Mokhtari-Esbuie,Farzad, Szeglin,Bryan, Ravari,MohsenRouhani, Duncan,Mark, Harmon,JohnW]
通讯作者: Harmon,JohnW
Revolutionary transformation lowering the mortality of pancreaticoduodenectomy: a historical review.
降低胰十二指肠切除术死亡率的革命性转变:历史回顾。
DOI: 10.1136/egastro-2023-100014
发表时间: 2023
期刊: eGastroenterology
影响因子: --
作者: [ChangWu,Bo, Wlodarczyk,Jakub, NourmohammadiAbadchi,Sanaz, Shababi,Niloufar, Cameron,JohnL, Harmon,JohnW]
通讯作者: Harmon,JohnW
Controlling Exosome Noncoding RNA Cargo for Enhanced Wound Healing
  • 批准号:
    9907865
  • 项目类别:
  • 资助金额:
    $37.61万
  • 财政年份:
    2018
  • 负责人:
    Steven Michael Jay
  • 依托单位:
Engineering NRG signaling for therapeutic vascularization in diabetic wounds
  • 批准号:
    8278926
  • 项目类别:
  • 资助金额:
    $9.09万
  • 财政年份:
    2012
  • 负责人:
    Steven Michael Jay
  • 依托单位:
Engineering NRG Signaling For Therapeutic Vascularization In Diabetic Wounds
  • 批准号:
    8475652
  • 项目类别:
  • 资助金额:
    $9.09万
  • 财政年份:
    2012
  • 负责人:
    Steven Michael Jay
  • 依托单位:
Engineering NRG Signaling For Therapeutic Vascularization In Diabetic Wounds
  • 批准号:
    8639621
  • 项目类别:
  • 资助金额:
    $23.7万
  • 财政年份:
    2012
  • 负责人:
    Steven Michael Jay
  • 依托单位:
海外基金